Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Wiley Interdiscip Rev Syst Biol Med. 2016 Mar 22;8(3):242–252. doi: 10.1002/wsbm.1332

Figure 1.

Figure 1

Simulation of therapy using a replicating virus, model (1). The virus is administered once, as indicated by the arrow. Shading indicates the phase of the dynamics following administration of the virus. (i) Use of a weakly cytopathic virus results in sustained cancer remission. (ii) Use of a more cytopathic virus results in long term persistence of the cancer and the virus.